BOLDEN THERAPEUTICS, INC.
Providence, RI · Biotech · Private
Antisense oligonucleotide (ASO) therapeutics targeting Adult Hippocampal Neurogenesis pathway to treat Alzheimer's disease
- Grants
- $2.7M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Promoting adult hippocampal neurogenesis in Alzheimer's Disease using an antibody-based therapy | $896,914 | |
| Federal grant | Department of Health and Human Services · Phase I · Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy | $497,550 | |
| Federal grant | Department of Health and Human Services · Phase I · Entrepreneurial development award for a novel Alzheimer's disease therapeutic | $406,466 | |
| Federal grant | Department of Health and Human Services · Phase I · Promoting adult hippocampal neurogenesis in Alzheimer's Disease using an antibody-based therapy | $396,914 | |
| Federal grant | Department of Health and Human Services · Phase I · Preclinical characterization of splice-modifying antisense oligonucleotides targeting neurogenesis in human AD neural cells | $504,505 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2975 | INVVAX, INC. | — | — |
| 2976 | CAMBIUM ONCOLOGY LLC | — | — |
| 2977 | MEDICATIONS DISCOVERY TEXAS, INC. | — | — |
| 2978 | BOLDEN THERAPEUTICS, INC. | — | — |
| 2979 | Navire Pharma | — | — |
| 2980 | POW GENETIC SOLUTIONS, INC. | — | — |
| 2981 | QUORUM INNOVATIONS, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Musk-targeting Oligonucleotidesapplication
- Musk-targeting Oligonucleotidesapplication
- Musk-targeting Oligonucleotidesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.